We estimated the serum levels of SCC-Ag, CEA and TPA in 69 patients with head or neck neoplasia and 31 healthy patients using a radioimmunometric method (double antibody). SCC-Ag concentrations were significantly increased in 43.4% cancer patients with respect to the cut-off point value (1.7 ng/ml) of the control group, and the specificity was 96.7%. The data varied according to the evolutive phase of disease. Since the combined evaluation of SCC-Ag, TPA and CEA serum levels increased the sensitivity, that was 71.0%, we thought it opportune to use all these markers in the tumoral pahtology taken into consideration.
CohnS.L., LincolnS.T., RosenS.Present status of serum tumor markers in diagnosis, prognosis and evaluation of therapy. Cancer Invest1986; 4(4): 305–27.
2.
Di NassoF.I markers tumorali nelle neoplasie maligne delle V.A.D.S. Acta Otorhinol Ital1987; 7(3): 245–82.
3.
KatoH., TorigoeT.Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer1977; 40: 1621–8.
4.
KatoH., MoriokaH., AramakiS., TorigoeT.Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cell Mol Biol1979; 25(1): 52–6.
5.
KatoH., MoriokaH., TsutsuiH., AramakiS., TorigoeT.Value of tumor antigen (TA-4) of squamous cell carcinoma in predicting the extent of cervical cancer. Cancer1982; 50(7): 1294–96.
6.
LunghiF., FrassonP., LunghiM.Antigene carcinoembrionale e carcinoma del distretto testa-collo. Acta Otorhinol Ital1985; 5: 371–6.
7.
MaruoT., ShibataK., KimaraA., OshinaM., Matsuto MokizukiM.Tumor associated antigen TA-4 in the monitoring of the effect of therapy for squamous cell carcinoma of the uterine cervix. Serial determination and tissue localisation. Cancer1985; 56(2): 302–8.
8.
PramikM.J.New assay for squamous cell carcinoma using most reliable tumor marker available. Genetic Engin New 27 April 1986; 97-8725 Ri.
9.
FishbachW.Proceeding of the Meeting “The use of SCC-RIA in the management of squamous cell carcinoma”. Nice, France, Novembre 1986.
10.
TurbaE., MarchettiC., PedriniP., FiniA., BrillanteC.Il dosaggio dello squamous cell carcinoma related antigen (SCC) nello studio delle neoplasie del cavo orale -3 Congresso Internazionale sui Markers Tumorali. Naples, 14-16 September, 1987.
11.
UedaG., IncoueY., YanasakiM.Immunohistochemical demonstration of tumor antigen TA-4 in gynaecologic tumors. Int L Gynaecol Pathol1984; 3(3): 291–8.
